Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-21-000004

Options or other derivatives

  • Director acquired 1,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Baxter Nicholas W Director 2021-04-26 Grant or award · Stock Options +1,500 6,500 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…